Should You Buy Exagen Inc (XGN) Stock After it Has Fallen 7.61% in a Week?

Overall market sentiment has been down on Exagen Inc (XGN) stock lately. XGN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Exagen Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on XGN!

See Full XGN Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With XGN Stock Today?

Exagen Inc (XGN) stock has gained 8.33% while the S&P 500 has fallen -1.01% as of 1:44 PM on Wednesday, Oct 18. XGN is higher by $0.14 from the previous closing price of $1.68 on volume of 21,036 shares. Over the past year the S&P 500 has gained 17.71% while XGN has fallen -27.78%. XGN lost -$2.03 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Exagen Inc click here.

More About Exagen Inc

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Click Here to get the full Stock Report for Exagen Inc stock.